all news stories

Sensars secures EUR 1.1 million in funding to advance revolutionary neuromodulation technology

Sensars, a leader in neuromodulation technology, has successfully secured EUR 1.1 million in funding to boost the development of its innovative SENSY product. The funding will help Sensars develop advanced solutions for chronic pain relief, bringing new hope to millions of sufferers worldwide